Financial results - INDIVIDUALIZED ONCOLOGY MEDICINE CONSULTING S.R.L.

Financial Summary - Individualized Oncology Medicine Consulting S.r.l.
Unique identification code: 46590708
Registration number: J23/5209/2022
Nace: 8622
Sales - Ron
54.914
Net Profit - Ron
27.313
Employees
2
Open Account
Company Individualized Oncology Medicine Consulting S.r.l. with Fiscal Code 46590708 recorded a turnover of 2024 of 54.914, with a net profit of 27.313 and having an average number of employees of 2. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Individualized Oncology Medicine Consulting S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 5.311 4.821 54.914
Total Income - EUR - - - - - - - 5.311 4.821 54.914
Total Expenses - EUR - - - - - - - 1.647 4.031 25.986
Gross Profit/Loss - EUR - - - - - - - 3.664 790 28.928
Net Profit/Loss - EUR - - - - - - - 3.507 514 27.313
Employees - - - - - - - 0 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1,045.5%, from 4.821 euro in the year 2023, to 54.914 euro in 2024. The Net Profit increased by 26.802 euro, from 514 euro in 2023, to 27.313 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Individualized Oncology Medicine Consulting S.r.l.

Rating financiar

Financial Rating -
INDIVIDUALIZED ONCOLOGY MEDICINE...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Individualized Oncology Medicine...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Individualized Oncology Medicine...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Individualized Oncology Medicine...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Individualized Oncology Medicine Consulting S.r.l. - CUI 46590708

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 16 960 1.182
Current Assets - - - - - - - 4.359 3.177 39.980
Inventories - - - - - - - 1.216 0 0
Receivables - - - - - - - 0 468 27.311
Cash - - - - - - - 3.143 2.710 12.669
Shareholders Funds - - - - - - - 3.548 563 27.362
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 828 3.575 13.800
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 39.980 euro in 2024 which includes Inventories of 0 euro, Receivables of 27.311 euro and cash availability of 12.669 euro.
The company's Equity was valued at 27.362 euro, while total Liabilities amounted to 13.800 euro. Equity increased by 26.802 euro, from 563 euro in 2023, to 27.362 in 2024.

Risk Reports Prices

Reviews - Individualized Oncology Medicine Consulting S.r.l.

Comments - Individualized Oncology Medicine Consulting S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.